Skip to content

A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06809647
Enrollment
10
Registered
2025-02-05
Start date
2025-03-30
Completion date
2026-08-30
Last updated
2025-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Open-Angle

Brief summary

The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.

Interventions

This is an implant-free, minimally invasive glaucoma surgery

Sponsors

PLU Ophthalmic
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Moderate to severe open angle glaucoma * Central corneal thickness between 480 and 610 microns

Exclusion criteria

* surgical history of corneal graft * presence of corneal opacities * Failed prior trabeculectomy

Design outcomes

Primary

MeasureTime frame
Intra Ocular pressure12 months
Use of concomitant topical glaucoma medications12 months

Countries

United States

Contacts

Primary ContactCarlos A Urrea, MD
CUrrea@pluophthalmic.com215-327-5500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026